Skip to main content
Epocrates Online
Contact us
Explore features
Reach clinicians
Buy now
By
vgreene
, 10 January, 2019
ASCVD
By
vgreene
, 10 January, 2019
alo
By
vgreene
, 10 January, 2019
albiglu
By
vgreene
, 10 January, 2019
If HBA1c still above target, use 1 of the following regimens:
By
vgreene
, 10 January, 2019
DPP4-I or SGLT2-I w/ lowest acquisition cost4
By
vgreene
, 10 January, 2019
insulin tx: basal insulin w/ lowest acquisition cost4 OR
By
vgreene
, 10 January, 2019
If HbA1c still above target, add additional agents as follows:
By
vgreene
, 10 January, 2019
If TZD chosen first: Add SU
By
vgreene
, 10 January, 2019
If SU chosen first: Add TZD
By
vgreene
, 10 January, 2019
Along w/ metformin, incorporate either an SU or TZD
Pagination
First page
Previous page
…
Page
2506
Page
2507
Page
2508
Page
2509
Current page
2510
Page
2511
Page
2512
Page
2513
Page
2514
…
Next page
Last page
About Us
Company Overview
Media Relations
Contact
Editorial Policy
Editorial Process
Third-Party Sponsorship Policy
athenahealth
Products
Core Products
Mobile CME
Product Licenses
Business Solutions
Pharma
Market Research
Institutions
Support
Support Center
Install
My Account
Stay Connected
Facebook
Twitter
YouTube